SMR · Investment summary · as of 29 July 2026
Priced for an operating path the record does not support
Business type: venture-like, not yet economically observable
The business does not meet the quality standard for its economic type.
At $8.21, SMR requires a 124% five-year revenue growth rate to justify its enterprise value — more than the business has ever demonstrated, at 15%.
The strongest argument against this view: Logged and scored; it rejects nothing.
| Question | Evidence-based conclusion |
|---|---|
| What drives the business? | Not determined — the operating driver is not stated in one place |
| What do we forecast? | Revenue growth of 15% demonstrated; an exit multiple of 22.5x. |
| What does Street forecast? | Not determined — no consensus estimates are joined to this record |
| Where do we differ? | On revenue growth, the difference between what the price requires and what the business has demonstrated is -109.1 percentage points. |
| What is it worth? | Not determined — To reach $53.5m NuScale must produce $52.9m across Q2-Q4 against a Q1 run-rate of $0.565m. |
| Why now? | Date not announced — no dated event that would resolve the disagreement is on file |
Not determined — no falsifiable operating conditions are on file for this name, so the thesis cannot be reduced to a small number of testable claims
Date not announced — no dated event that would resolve the disagreement is on file
Logged and scored; it rejects nothing. Inverse-volatility sizing is the active control — realised volatility is 100.0%. ---
Not determined — no falsifiable invalidation conditions are on file, so this position cannot be risk-monitored
Not determined — no upside discipline is stated, so there is no rule for how this position ends in a favourable outcome
| Criteria | Status | Investment meaning |
|---|---|---|
| Quality | Not met | Is the business worth owning under its declared economic type? |
| Valuation | Not met | Is the operating path required by today's price achievable? |
| Liquidity | Met | Can the intended position be built and exited in the right vehicle? |
| Downside | Met | Logged and scored; it rejects nothing. |
| Momentum | Not determined | Does price action support or complicate entry timing? Not established on the evidence on file. |
| Catalyst | Not determined | Is there a dated event that resolves the disagreement? Not established on the evidence on file. |
| Consensus | Not determined | Is the house-versus-Street disagreement identified and quantified? Not established on the evidence on file. |
Quality, valuation and liquidity can prevent a position on their own. The remaining four inform timing, sizing and monitoring, and never reject an investment by themselves.
The gap between what today's price requires and what the business has demonstrated is -109.1 percentage points, and that gap — not the multiple — is the case that the security is mispriced. The most important unresolved uncertainty is the permanent-loss mechanism: logged and scored; it rejects nothing. The next evidence that should change the portfolio decision is the next scheduled results, or a daily close below $6.20, which forces an immediate review.